GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » 3-Year Revenue Growth Rate

MDBIF (TrivarX) 3-Year Revenue Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX 3-Year Revenue Growth Rate?

TrivarX's Revenue per Share for the six months ended in Dec. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of TrivarX was 100.00% per year. The lowest was -63.20% per year. And the median was -40.80% per year.


Competitive Comparison of TrivarX's 3-Year Revenue Growth Rate

For the Health Information Services subindustry, TrivarX's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TrivarX's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where TrivarX's 3-Year Revenue Growth Rate falls into.


;
;

TrivarX 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


TrivarX  (OTCPK:MDBIF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


TrivarX 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of TrivarX's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

TrivarX Headlines

From GuruFocus

Medibio Announces Next Tranche of Corporate Health Contracts

By Marketwired Marketwired 05-10-2018

Medibio Granted CE Mark Approval for MEBsleep

By PRNewswire PRNewswire 01-19-2021

Medibio Submits FDA De Novo Application

By Marketwired Marketwired 07-16-2018

Medibio Provides Updated Company Presentation

By Marketwired Marketwired 10-05-2018

Medibio Releases Corporate Health Product, ilumen™

By Marketwired Marketwired 10-03-2018

Medibio Announces Scientific Advisory Board

By Marketwired Marketwired 04-26-2018